At Two Labs, our mission is to improve patients’ quality of life by delivering innovative trade and commercialization services to pharmaceutical manufacturers. This is why we’re pleased to announce that as of February 3, 2020, Two Labs has acquired CEEK Enterprises, a management consultancy focused on biopharma/med tech with specialized expertise in corporate development, commercial strategy, clinical development and medical affairs.
This acquisition strengthens our mission by adding complementary services that expand the suite of offerings our emerging pharma clients need to bring their life-saving drugs to market. We are uniting two value-driven pharma service providers that together, can support clients throughout the product lifecycle, from early product development through loss of exclusivity.
CEEK’s unique Clinical Development and Medical Affairs proficiencies, combined with their early stage Commercial and Corporate Strategy, enables our clients to better understand which products and indications are more likely to be successfully researched and commercialized. And much like Two Labs, the company delivers a tailored, personal, and professional experience to their customers, resulting in a reputation for delivering high quality service.
At Two Labs, we’re committed to staying at the forefront of the healthcare market, and the combined capabilities of our companies will help us continue to meet our clients’ evolving needs. We are excited for this growth and feel confident that CEEK is the perfect addition to the Two Labs team.
Thank you for your support and encouragement as Two Labs continues to grow.